Patents by Inventor Zoltan Zadori

Zoltan Zadori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180363071
    Abstract: The present invention provides methods for detecting viral infectivity and content in an enzyme preparation. In certain embodiments, the invention relates to methods for producing a pharmaceutical pancreatic enzyme composition. In additional embodiments, the invention relates to detecting infectious porcine parvovirus (PPV) and determining PPV content in pancreatic enzyme preparations (PEPs), including pancrelipase preparations.
    Type: Application
    Filed: August 10, 2018
    Publication date: December 20, 2018
    Inventors: Peter Tijssen, Jozsef Szelei, Zoltan Zadori
  • Patent number: 10087493
    Abstract: The present invention provides methods for detecting viral infectivity and content in an enzyme preparation. In certain embodiments, the invention relates to methods for producing a pharmaceutical pancreatic enzyme composition. In additional embodiments, the invention relates to detecting infectious porcine parvovirus (PPV) and determining PPV content in pancreatic enzyme preparations (PEPs), including pancrelipase preparations.
    Type: Grant
    Filed: March 9, 2009
    Date of Patent: October 2, 2018
    Assignee: APTALIS PHARMA CANADA ULC
    Inventors: Peter Tijssen, Jozsef Szelei, Zoltan Zadori
  • Patent number: 8603784
    Abstract: The invention relates to infectious clones of parvovirus B19, methods of cloning infectious B19 clones, and methods of cloning viral genomes that have secondary DNA structures that are unstable in bacterial cells. A B19 infectious clone and methods of producing B19 infectious clones are useful for producing infectious virus. Infectious virus is useful for identifying and developing therapeutically effective compositions for treatment and/or prevention of human parvovirus B19 infections.
    Type: Grant
    Filed: September 29, 2009
    Date of Patent: December 10, 2013
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, Institut National de Rechesche Scientifique
    Inventors: Kevin Edward Brown, Ning Zhi, Peter Tijssen, Zoltan Zadori
  • Publication number: 20100136514
    Abstract: The invention relates to infectious clones of parvovirus B19, methods of cloning infectious B19 clones, and methods of cloning viral genomes that have secondary DNA structures that are unstable in bacterial cells. A B19 infectious clone and methods of producing B19 infectious clones are useful for producing infectious virus. Infectious virus is useful for identifying and developing therapeutically effective compositions for treatment and/or prevention of human parvovirus B19 infections.
    Type: Application
    Filed: September 29, 2009
    Publication date: June 3, 2010
    Applicants: Government of the US, as represented by the Secretary, Department of Health and Human Services
    Inventors: Kevin Edward Brown, Ning Zhi, Peter Tijssen, Zoltan Zadori
  • Patent number: 7598071
    Abstract: The invention relates to infectious clones of parvovirus B19, methods of cloning infectious B19 clones, and methods of cloning viral genomes that have secondary DNA structures that are unstable in bacterial cells. A B19 infectious clone and methods of producing B19 infectious clones are useful for producing infectious virus. Infectious virus is useful for identifying and developing therapeutically effective compositions for treatment and/or prevention of human parvovirus B19 infections.
    Type: Grant
    Filed: July 9, 2004
    Date of Patent: October 6, 2009
    Assignees: The United States of America as represented by the Department of Health and Human Services, Institut National de Recherche Scientifique
    Inventors: Kevin Brown, Ning Zhi, Peter Tijssen, Zoltan Zadori
  • Publication number: 20090226414
    Abstract: The present invention provides methods for detecting viral infectivity and content in an enzyme preparation. In certain embodiments, the invention relates to methods for producing a pharmaceutical pancreatic enzyme composition. In additional embodiments, the invention relates to detecting infectious porcine parvovirus (PPV) and determining PPV content in pancreatic enzyme preparations (PEPs), including pancrelipase preparations.
    Type: Application
    Filed: March 9, 2009
    Publication date: September 10, 2009
    Applicant: Axcan Pharma Inc.
    Inventors: Peter Tijssen, Jozsef Szelei, Zoltan Zadori
  • Publication number: 20060008469
    Abstract: The invention relates to infectious clones of parvovirus B19, methods of cloning infectious B19 clones, and methods of cloning viral genomes that have secondary DNA structures that are unstable in bacterial cells. A B19 infectious clone and methods of producing B19 infectious clones are useful for producing infectious virus. Infectious virus is useful for identifying and developing therapeutically effective compositions for treatment and/or prevention of human parvovirus B19 infections.
    Type: Application
    Filed: July 9, 2004
    Publication date: January 12, 2006
    Applicant: Government of the United States, as represented by the Secretary, Dept. of Health and Human Services
    Inventors: Kevin Brown, Ning Zhi, Peter Tijssen, Zoltan Zadori